Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,252 | 35,277 | 88,227 | 25,218 | 198,955 |
| Marketable Securities | 210,974 | 268,339 | 416,750 | 708,737 | 862,941 |
| Receivables | N/A | 1,205 | 5,981 | 22,492 | 38,889 |
| Inventories | N/A | 16,101 | 19,202 | 15,801 | 15,292 |
| Other current assets | 6,066 | 9,779 | 15,808 | 23,333 | 21,928 |
| TOTAL | $261,292 | $330,701 | $545,968 | $795,581 | $1,138,005 |
| Non-Current Assets | |||||
| PPE Net | 3,411 | 18,856 | 32,451 | 60,510 | 59,662 |
| Investments And Advances | 26,087 | 25,825 | 0 | 64,828 | 136,662 |
| Intangibles | 0 | 0 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 13,060 | 22,651 | 55,680 | 119,769 | 127,937 |
| TOTAL | $42,558 | $67,332 | $164,632 | $321,608 | $400,762 |
| Total Assets | $303,850 | $398,033 | $710,600 | $1,117,189 | $1,538,767 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,560 | 9,848 | 12,980 | 9,747 | 22,139 |
| Accrued Expenses | 29,972 | 22,162 | 36,557 | 42,544 | 58,739 |
| TOTAL | $61,400 | $51,269 | $68,204 | $85,200 | $115,779 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 181,713 | 215,777 | 275,758 | 352,481 | 345,693 |
| TOTAL | $181,713 | $215,777 | $275,758 | $352,481 | $345,693 |
| Total Liabilities | $243,113 | $267,046 | $343,962 | $437,681 | $461,472 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,413 | 12,247 | 12,622 | 12,424 | 12,152 |
| Common Shares | 19 | 19 | 19 | 19 | 18 |
| Retained earnings | -3,596,210 | -3,477,249 | -3,201,193 | -2,832,995 | -2,309,158 |
| Other shareholders' equity | 61 | 80 | -6,907 | -4,157 | -2,295 |
| TOTAL | $60,737 | $130,987 | $366,638 | $679,508 | $1,077,295 |
| Total Liabilities And Equity | $303,850 | $398,033 | $710,600 | $1,117,189 | $1,538,767 |